Thermosensitive PEG–PCL–PEG Hydrogel Controlled Drug Delivery System: Sol–Gel–Sol Transition and In Vitro Drug Release Study

In this article, biodegradable and low molecular weight poly(ethylene glycol)–poly(ε-caprolactone)–poly(ethylene glycol) (PEG–PCL–PEG, PECE) triblock copolymers were successfully synthesized. Aqueous solution of the obtained PECE copolymers underwent sol–gel–sol transition as temperature increased w...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical sciences Vol. 98; no. 10; pp. 3707 - 3717
Main Authors Gong, Chang Yang, Dong, Peng Wei, Shi, Shuai, Fu, Shao Zhi, Yang, Jin Liang, Guo, Gang, Zhao, Xia, Wei, Yu Quan, Qian, Zhi Yong
Format Journal Article
LanguageEnglish
Published Hoboken Elsevier Inc 01.10.2009
Wiley Subscription Services, Inc., A Wiley Company
Wiley
American Pharmaceutical Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this article, biodegradable and low molecular weight poly(ethylene glycol)–poly(ε-caprolactone)–poly(ethylene glycol) (PEG–PCL–PEG, PECE) triblock copolymers were successfully synthesized. Aqueous solution of the obtained PECE copolymers underwent sol–gel–sol transition as temperature increased which was flowing sol at room temperature and then turned into nonflowing gel at body temperature. Sol–gel–sol phase transition behaviors of aqueous PECE solutions were studied using rheometry and test tube-inverting method, which were affected by many factors, including the heating/cooling procedure and different additives in copolymers aqueous solution. In vitro drug release behavior was studied using bovine serum albumin (BSA) and Vitamin B12 (VB12) as model drugs, and the PECE hydrogel could protect BSA from acidic degradation for 1 week at least. Therefore, PECE hydrogel is believed to be promising for injectable in situ gel-forming controlled drug delivery system due to their great thermosensitivity and biodegradability. © 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:3707–3717, 2009
Bibliography:Dong PW and Gong CY contributed equally to this work.
istex:CF456F69E979F4A1366EE41CB3CBC93A4898533A
ArticleID:JPS21694
ark:/67375/WNG-16L9472Z-H
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-3549
1520-6017
1520-6017
DOI:10.1002/jps.21694